Literature DB >> 23192311

Effect of angiotensin II on spatial memory, cerebral blood flow, cholinergic neurotransmission, and brain derived neurotrophic factor in rats.

Santoshkumar Tota1, Ruby Goel, Shakti Deep Pachauri, N Rajasekar, Abul Kalam Najmi, Kashif Hanif, Chandishwar Nath.   

Abstract

RATIONAL: Studies have shown the involvement of angiotensin II (Ang II) in neurobehavioral aspects, but the exact role of Ang II in memory is still ambiguous.
OBJECTIVE: This study explored the effect of central Ang II on spatial memory along with cholinergic neurotransmission, brain energy metabolism, cerebral blood flow (CBF), and brain-derived neurotrophic factor (BDNF) in rats.
METHODS: Spatial memory was evaluated by Morris water maze (MWM) after Ang II (ICV) administration in male Sprague-Dawley rats. CBF was measured by laser Doppler flowmetry. Oxidative stress adenosine triphosphate (ATP), BDNF, acetylcholinesterase (AChE), and acetylcholine (ACh) were estimated in the cortex and hippocampus at 1, 24, and 48 h after Ang II administration. The effect of AT1 and AT2 receptor blocker (candesartan and PD123,319, respectively), AChE inhibitor (donepezil), and antioxidant melatonin was studied on memory, CBF, and biochemical parameters.
RESULTS: Ang II caused spatial memory impairment by affecting acquisition, consolidation, and recall in the MWM test along with a significant reduction in CBF. Ang II significantly reduced ACh level and caused oxidative stress in the rat brain 1 h post-injection. No significant change was observed in BDNF, AChE, and ATP level. Candesartan and donepezil prevented Ang II-induced memory impairment, reduction in CBF and ACh level. However, PD123,319 and melatonin failed to prevent Ang II-induced memory impairment but improved CBF partially.
CONCLUSION: This study suggests that Ang II, via the AT1 receptor, affects spatial memory formation, CBF, and ACh level while AT2 receptor has no significant role.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192311     DOI: 10.1007/s00213-012-2913-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

Review 1.  On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.

Authors:  R T Bartus
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

2.  The coupling of a trkB tyrosine residue to LTP.

Authors:  Patrik Ernfors; Clive R Bramham
Journal:  Trends Neurosci       Date:  2003-04       Impact factor: 13.837

3.  Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease.

Authors:  Kazumasa Kume; Haruo Hanyu; Hirofumi Sakurai; Yusuke Takada; Takeshi Onuma; Toshihiko Iwamoto
Journal:  Geriatr Gerontol Int       Date:  2011-09-19       Impact factor: 2.730

4.  Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: a behavioral, biochemical and cerebral blood flow study.

Authors:  Shakti Deep Pachauri; Santoshkumar Tota; Kiran Khandelwal; P R P Verma; Chandishwar Nath; Kashif Hanif; Rakesh Shukla; J K Saxena; Anil Kumar Dwivedi
Journal:  J Ethnopharmacol       Date:  2011-11-15       Impact factor: 4.360

5.  Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.

Authors:  Santoshkumar Tota; Pradeep Kumar Kamat; Rakesh Shukla; Chandishwar Nath
Journal:  Behav Brain Res       Date:  2011-03-04       Impact factor: 3.332

Review 6.  Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies.

Authors:  Behnam Sabayan; Steffy Jansen; Anna M Oleksik; Matthias J P van Osch; Mark A van Buchem; Peter van Vliet; Anton J M de Craen; Rudi G J Westendorp
Journal:  Ageing Res Rev       Date:  2011-12-27       Impact factor: 10.895

7.  Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism.

Authors:  Daniel S Kerr; Lia R M Bevilaqua; Juliana S Bonini; Janine I Rossato; Cristiano A Köhler; Jorge H Medina; Iván Izquierdo; Martín Cammarota
Journal:  Psychopharmacology (Berl)       Date:  2004-11-17       Impact factor: 4.530

8.  Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.

Authors:  B K Saxby; F Harrington; K A Wesnes; I G McKeith; G A Ford
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

9.  Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.

Authors:  D Wyper; E Teasdale; J Patterson; D Montaldi; D Brown; R Hunter; D Graham; J McCulloch
Journal:  Br J Radiol       Date:  1993-01       Impact factor: 3.039

10.  Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study.

Authors:  Ghazi Ahmad Radaideh; Patrick Choueiry; Amr Ismail; Elie Eid; Jean-Pascal Berrou; Armand Sedefdjian; Frank Sévenier; Atul Pathak
Journal:  Vasc Health Risk Manag       Date:  2011-08-01
View more
  18 in total

1.  Antihypertensive drug Valsartan promotes dendritic spine density by altering AMPA receptor trafficking.

Authors:  Young In Sohn; Nathanael J Lee; Andrew Chung; Juan M Saavedra; R Scott Turner; Daniel T S Pak; Hyang-Sook Hoe
Journal:  Biochem Biophys Res Commun       Date:  2013-09-06       Impact factor: 3.575

2.  Ameliorative effect of kolaviron, a biflavonoid complex from Garcinia kola seeds against scopolamine-induced memory impairment in rats: role of antioxidant defense system.

Authors:  Ismail O Ishola; Folasade M Adamson; Olufunmilayo O Adeyemi
Journal:  Metab Brain Dis       Date:  2016-09-08       Impact factor: 3.584

3.  Effects of Hypericum scabrum extract on learning and memory and oxidant/antioxidant status in rats fed a long-term high-fat diet.

Authors:  Ahmad Ganji; Iraj Salehi; Masoumeh Nazari; Masoumeh Taheri; Alireza Komaki
Journal:  Metab Brain Dis       Date:  2017-05-24       Impact factor: 3.584

Review 4.  The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy.

Authors:  Natasha Ivanova; Jana Tchekalarova
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

Review 5.  Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role?

Authors:  Parul Bali; Debomoy K Lahiri; Avijit Banik; Bimla Nehru; Akshay Anand
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

6.  Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice.

Authors:  Rachel L Poole; David A Connor; Thomas J Gould
Journal:  Behav Neurosci       Date:  2014-06-09       Impact factor: 1.912

7.  Role of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonism.

Authors:  Tauheed Ishrat; Anna Kozak; Ahmed Alhusban; Bindu Pillai; Maribeth H Johnson; Azza B El-Remessy; Adviye Ergul; Susan C Fagan
Journal:  Stroke Res Treat       Date:  2014-07-24

Review 8.  The Brain AT2R-a Potential Target for Therapy in Alzheimer's Disease and Vascular Cognitive Impairment: a Comprehensive Review of Clinical and Experimental Therapeutics.

Authors:  Heba A Ahmed; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2020-06-12       Impact factor: 5.682

9.  Panax notoginsenoside Rb1 ameliorates Alzheimer's disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expression.

Authors:  Yu Wang; Yu Feng; Qunying Fu; Lei Li
Journal:  Exp Ther Med       Date:  2013-07-11       Impact factor: 2.447

Review 10.  A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.

Authors:  John W Wright; Leen H Kawas; Joseph W Harding
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.